Strategies to Counteract Resistance Mechanisms in CAR+ T-Cell-Based Immunotherapy for Triple-Negative Breast Cancer
Abstract
This is the final report of our awarded proposal entitled "Strategies to Counteract Resistance Mechanisms in CAR T-Cell Based Immunotherapy for Triple-Negative Breast Cancer". The goal of this proposal is to test the in vitro and in vivo anti-tumor activity of the CSPG4-specific CAR T cell combinatorial immunotherapeutic strategy we have developed for the treatment of TNBC. Given the limited in vivo effectiveness of our strategy, we have tested a plethora of strategies aiming to enhance the ant-tumor activity of CSPG4 CAR T cells via distinct approaches and mechanisms.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2020
- Accession Number
- AD1154909
Entities
People
- Barbara Savoldo
- Gianpietro Dotti
Organizations
- University of North Carolina at Chapel Hill